Patients facing a glioma diagnosis often encounter complex choices about their next steps in treatment. Here, Dr. Michal Nisnboym Ziv helps outline the key considerations for treating the disease. Dr.
Targeted IDH inhibitors–targeted cancer treatments that are generally well-tolerated by most patients–have reshaped treatment for many glioma patients—but doctors say careful liver monitoring is a key ...
A brain tumor diagnosis can profoundly affect how a person thinks, feels, and experiences the world. Patients often describe an emotional rollercoaster that includes fear, sadness, uncertainty, and ...
Here, Dr. Nick Gonzalez Castro helps outline the key considerations for treating the disease. A graduate of Harvard University who completed his neurology residence at Harvard Medical School, Dr. Nick ...
Patients facing a glioma diagnosis often encounter complex choices about their next steps in treatment. Here, Dr. Juan Pablo Ospina helps outline the key considerations for treating the disease. Dr.
Radiation therapy is a cornerstone in the treatment of many gliomas, particularly when used alongside surgery and sometimes chemotherapy. Each patient’s treatment is customized based on the tumor’s ...
With better surgery, smarter imaging, and targeted drugs like IDH inhibitors, the story of low-grade glioma is increasingly one of long-term disease management. Still, any glioma diagnosis is ...
Radiation therapy is one of the most effective treatments available for people with gliomas. It uses targeted, high-energy beams to slow tumor growth and help improve symptoms such as headaches, ...
Dr. Juan Pablo Ospina offers guidance to help glioma patients understand their condition and navigate treatment. He advises working closely with a team of specialists, tailoring therapy to individual ...
For patients facing low-grade glioma, the targeted drug vorasidenib has emerged as a milestone treatment option. It is the first systemic therapy specifically for people with certain gliomas with ...
A new FDA-approved treatment for HER2-positive metastatic breast cancer—trastuzumab deruxtecan (Enhertu) in combination with pertuzumab (Perjeta)—has prompted excitement among experienced breast ...
After glioma treatment, follow-up care plays a crucial role in watching for possible tumor changes, managing symptoms, and supporting long-term well-being. How you will be monitored depends on your ...